Bivalirudin in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: uncertainties almost clarified.
3rd Department of Internal Medicine, Cardiology and Intensive Care Medicine, Wilhelminenspital, Vienna, and Sigmund Freud Private University, Medical School, Vienna, Austria.
Kurt
K
Huber
Freek W A
FW
Verheugt
D000925:Anticoagulants; D006493:Heparin; D006629:Hirudins; D006801:Humans; D009203:Myocardial Infarction; D010446:Peptide Fragments; D062645:Percutaneous Coronary Intervention; D011994:Recombinant Proteins; D000072657:ST Elevation Myocardial Infarction; D016896:Treatment Outcome
D000925:Anticoagulants; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; D006493:Heparin; C074619:bivalirudin